TrialJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society2015

Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of life.

Salim Chahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.